High expression of high-mobility group box 1 in the blood and lungs is associated with the development of chronic obstructive pulmonary disease in smokers

HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection

(2011) Ulf Andersson et al.   Annual Review of Immunology

Validity of HMGB1 measurement in epithelial lining fluid in patients with COPD

(2011) Hiroshi Kanazawa et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Expression of High-Mobility Group Box 1 and of Receptor for Advanced Glycation End Products in Chronic Obstructive Pulmonary Disease

(2010) Nassima Ferhani et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

HMGB1 and RAGE in Inflammation and Cancer

(2010) Gary P. Sims et al.   Annual Review of Immunology

High-Mobility Group Box 1, Oxidative Stress, and Disease

(2010) Daolin Tang et al.   ANTIOXIDANTS & REDOX SIGNALING

Prevalence of airflow obstruction in smokers and never-smokers in Switzerland

(2010) P.-O. Bridevaux et al.   EUROPEAN RESPIRATORY JOURNAL

Unknown

(2010) Hanna Schierbeck et al.   MOLECULAR MEDICINE

HMGB1 loves company

(2009) Marco E. Bianchi   JOURNAL OF LEUKOCYTE BIOLOGY

Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer

(2009) Guan-Hong Shang et al.   RESPIRATORY MEDICINE

Potential Role of High-Mobility Group Box 1 in Cystic Fibrosis Airway Disease

(2008) Steven M. Rowe et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Non-reversible airway obstruction in never smokers: Results from the Austrian BOLD study

(2008) B. Lamprecht et al.   RESPIRATORY MEDICINE